irsogladine has been researched along with Stomach Neoplasms in 2 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 60-year-old woman with gastric cancer had undergone partial gastrectomy in September 1989." | 1.28 | Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate. ( Hosokawa, T; Kajiwara, T; Ogawa, K; Otani, Y, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugie, S | 1 |
| Okamoto, K | 1 |
| Watanabe, T | 1 |
| Tanaka, T | 1 |
| Mori, H | 1 |
| Hosokawa, T | 1 |
| Otani, Y | 1 |
| Ogawa, K | 1 |
| Kajiwara, T | 1 |
2 other studies available for irsogladine and Stomach Neoplasms
| Article | Year |
|---|---|
Suppressive effect of irsogladine maleate on N-methyl-N-nitro-N-nitrosoguanidine (MNNG)-initiated and glyoxal-promoted gastric carcinogenesis in rats.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Drug Interactions; Glyoxal; Liver Neoplasms; Male; Me | 2001 |
Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate.
Topics: Abdominal Neoplasms; Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 1992 |